233 related articles for article (PubMed ID: 8752951)
1. Human IgG monoclonal antibodies that modulate the binding of specific IgE to birch pollen Bet v 1.
Visco V; Dolecek C; Denépoux S; Le Mao J; Guret C; Rousset F; Guinnepain MT; Kraft D; Valenta R; Weyer A; Banchereau J; Labecque S
J Immunol; 1996 Jul; 157(2):956-62. PubMed ID: 8752951
[TBL] [Abstract][Full Text] [Related]
2. Mapping of conformational IgE epitopes with peptide-specific monoclonal antibodies reveals simultaneous binding of different IgE antibodies to a surface patch on the major birch pollen allergen, Bet v 1.
Gieras A; Cejka P; Blatt K; Focke-Tejkl M; Linhart B; Flicker S; Stoecklinger A; Marth K; Drescher A; Thalhamer J; Valent P; Majdic O; Valenta R
J Immunol; 2011 May; 186(9):5333-44. PubMed ID: 21451110
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterization of Bip 1, a monoclonal antibody that modulates IgE binding to birch pollen allergen, Bet v 1.
Laffer S; Vangelista L; Steinberger P; Kraft D; Pastore A; Valenta R
J Immunol; 1996 Dec; 157(11):4953-62. PubMed ID: 8943401
[TBL] [Abstract][Full Text] [Related]
4. Kinetics, cross-reactivity, and specificity of Bet v 1-specific IgG4 antibodies induced by immunotherapy with birch pollen.
Subbarayal B; Schiller D; Möbs C; de Jong NW; Ebner C; Reider N; Bartel D; Lidholm J; Pfützner W; Gerth van Wijk R; Vieths S; Bohle B
Allergy; 2013 Nov; 68(11):1377-86. PubMed ID: 24053565
[TBL] [Abstract][Full Text] [Related]
5. Expression of a human IgG4 antibody, BAB2, with specificity for the major Birch pollen allergen, Bet v 1 in Escherichia coli: recombinant BAB2 Fabs enhance the allergic reaction.
Eibensteiner P; Denépoux S; Steinberger P; Kraft D; Visco V; Banchereau J; Lebecque S; Valenta R
Int Arch Allergy Immunol; 1999; 118(2-4):190-2. PubMed ID: 10224374
[TBL] [Abstract][Full Text] [Related]
6. Gastrointestinal digestion of Bet v 1-homologous food allergens destroys their mediator-releasing, but not T cell-activating, capacity.
Schimek EM; Zwölfer B; Briza P; Jahn-Schmid B; Vogel L; Vieths S; Ebner C; Bohle B
J Allergy Clin Immunol; 2005 Dec; 116(6):1327-33. PubMed ID: 16337467
[TBL] [Abstract][Full Text] [Related]
7. Immunoblotting in the diagnosis of cross-reactivity in children allergic to birch.
Cudowska B; Kaczmarski M; Restani P
Rocz Akad Med Bialymst; 2005; 50():268-73. PubMed ID: 16358981
[TBL] [Abstract][Full Text] [Related]
8. Immunologic characterization of monoclonal antibodies that modulate human IgE binding to the major birch pollen allergen Bet v 1.
Lebecque S; Dolecek C; Laffer S; Visco V; Denépoux S; Pin JJ; Guret C; Boltz-Nitulescu G; Weyer A; Valenta R
J Allergy Clin Immunol; 1997 Mar; 99(3):374-84. PubMed ID: 9058694
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the antibody responses induced by subcutaneous injection immunotherapy with birch and Fagales pollen extracts adsorbed onto aluminum hydroxide.
Gadermaier E; Flicker S; Aberer W; Egger C; Reider N; Focke M; Vrtala S; Kundi M; Valenta R
Int Arch Allergy Immunol; 2010; 151(1):17-27. PubMed ID: 19672093
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the T cell response to the major hazelnut allergen, Cor a 1.04: evidence for a relevant T cell epitope not cross-reactive with homologous pollen allergens.
Bohle B; Radakovics A; Lüttkopf D; Jahn-Schmid B; Vieths S; Ebner C
Clin Exp Allergy; 2005 Oct; 35(10):1392-9. PubMed ID: 16238801
[TBL] [Abstract][Full Text] [Related]
11. Dominant epitopes and allergic cross-reactivity: complex formation between a Fab fragment of a monoclonal murine IgG antibody and the major allergen from birch pollen Bet v 1.
Mirza O; Henriksen A; Ipsen H; Larsen JN; Wissenbach M; Spangfort MD; Gajhede M
J Immunol; 2000 Jul; 165(1):331-8. PubMed ID: 10861069
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a hypoallergenic recombinant Bet v 1 variant as a candidate for allergen-specific immunotherapy.
Kahlert H; Suck R; Weber B; Nandy A; Wald M; Keller W; Cromwell O; Fiebig H
Int Arch Allergy Immunol; 2008; 145(3):193-206. PubMed ID: 17912007
[TBL] [Abstract][Full Text] [Related]
13. Ara h 8, a Bet v 1-homologous allergen from peanut, is a major allergen in patients with combined birch pollen and peanut allergy.
Mittag D; Akkerdaas J; Ballmer-Weber BK; Vogel L; Wensing M; Becker WM; Koppelman SJ; Knulst AC; Helbling A; Hefle SL; Van Ree R; Vieths S
J Allergy Clin Immunol; 2004 Dec; 114(6):1410-7. PubMed ID: 15577846
[TBL] [Abstract][Full Text] [Related]
14. Allergen mimotopes for 3-dimensional epitope search and induction of antibodies inhibiting human IgE.
Ganglberger E; Grunberger K; Sponer B; Radauer C; Breiteneder H; Boltz-Nitulescu G; Scheiner O; Jensen-Jarolim E
FASEB J; 2000 Nov; 14(14):2177-84. PubMed ID: 11053238
[TBL] [Abstract][Full Text] [Related]
15. Bet v 1, the major birch pollen allergen, initiates sensitization to Api g 1, the major allergen in celery: evidence at the T cell level.
Bohle B; Radakovics A; Jahn-Schmid B; Hoffmann-Sommergruber K; Fischer GF; Ebner C
Eur J Immunol; 2003 Dec; 33(12):3303-10. PubMed ID: 14635038
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of human IgG monoclonal antibodies specific for the major birch pollen allergen Bet v 1. Anti-allergen IgG can enhance the anaphylactic reaction.
Denépoux S; Eibensteiner PB; Steinberger P; Vrtala S; Visco V; Weyer A; Kraft D; Banchereau J; Valenta R; Lebecque S
FEBS Lett; 2000 Jan; 465(1):39-46. PubMed ID: 10620703
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal IgE antibodies against birch pollen allergens: novel tools for biological characterization and standardization of allergens.
Kaul S; Scheurer S; Danz N; Schicktanz S; Vieths S; Hoffmann A
J Allergy Clin Immunol; 2003 Jun; 111(6):1262-8. PubMed ID: 12789227
[TBL] [Abstract][Full Text] [Related]
18. A sensitive assay for the detection of IgE bound to the major birch pollen allergen, Bet v 1, in the form of immune complexes.
Pree I; Reisinger J; Bohle B; Frantal S; Valenta R; Niederberger V
J Immunol Methods; 2009 Jun; 345(1-2):100-5. PubMed ID: 19376122
[TBL] [Abstract][Full Text] [Related]
19. IgE mimotopes of birch pollen allergen Bet v 1 induce blocking IgG in mice.
Ganglberger E; Grünberger K; Wiedermann U; Vermes M; Sponer B; Breiteneder H; Scheiner O; Boltz G; Jensen-Jarolim E
Int Arch Allergy Immunol; 2001; 124(1-3):395-7. PubMed ID: 11307026
[TBL] [Abstract][Full Text] [Related]
20. Birch pollen immunotherapy results in long-term loss of Bet v 1-specific TH2 responses, transient TR1 activation, and synthesis of IgE-blocking antibodies.
Möbs C; Ipsen H; Mayer L; Slotosch C; Petersen A; Würtzen PA; Hertl M; Pfützner W
J Allergy Clin Immunol; 2012 Nov; 130(5):1108-1116.e6. PubMed ID: 23021882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
